Endotoxin impairs biliary glutathione and HCO3- excretion and blocks the choleretic effect of nitric oxide in rat liver

被引:52
作者
Trauner, M
Nathanson, MH
Rydberg, SA
Koeppel, TA
Gartung, C
Sessa, WC
Boyer, JL
机构
[1] YALE UNIV, SCH MED, DEPT INTERNAL MED, NEW HAVEN, CT 06510 USA
[2] YALE UNIV, SCH MED, CTR LIVER, NEW HAVEN, CT 06510 USA
[3] YALE UNIV, SCH MED, DEPT PHARMACOL, NEW HAVEN, CT 06510 USA
关键词
D O I
10.1002/hep.510250522
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cholestasis in patients with sepsis has been attributed to the effects of endotoxin (lipopolysaccharides, LPS) and LPS-induced cytokines, which are also potent stimulators of systemic and hepatic nitric oxide (NO) synthesis, NO donors stimulate bile acid-independent bile flow in normal rat liver, but the effects of LPS-induced NO on bile formation remain unclear, To address this question we examined the effects of NO and its mediator guanosine 3',5'-cyclic monophosphate (cGMP) on bile now and biliary HCO3- and glutathione excretion in isolated perfused rat livers (IPRL) from LPS-treated rats, Portal and systemic NO2- + NO3- plasma levels were increased 47-fold in LPS-treated rats and were also elevated in perfusate (6-fold) and bile (9-fold) after isolating and perfusing livers from these animals. Bile flow, HCO3-, and glutathione output were decreased by 33%, 25%, and 81% in these IPRL, respectively, Stimulation of NO synthesis with L-arginine or inhibition of inducible NO synthesis with aminoguanidine did not change bile flow, although pretreatment with aminoguanidine inhibited NO production by 85%. Moreover, the choleretic effects of infusions of the NO donors sodium nitroprusside (SNP) and S-nitroso-acetyl-penicillamine were markedly reduced in endotoxemic IPRL compared with normal controls, and SNP-induced HCO3- and glutathione excretion were reduced by 61% and 86%, respectively, SNP-induced cyclic GMP production was 2.3-fold lower than in normals, but the choleretic effect of dibutyryl cGMP was only slightly reduced in endotoxemic livers, These findings indicate that LPS reduces bile acid-independent bile flow primarily by inhibiting biliary excretion of glutathione and to a lesser extent HCO3-, whereas LPS-induced NO does not modulate bile formation in endotoxemia. Thus, impairment of the major determinants of bile acid-independent bile now by LPS may contribute significantly to the pathogenesis of the cholestasis of sepsis.
引用
收藏
页码:1184 / 1191
页数:8
相关论文
共 47 条
[1]  
Abrams G A, 1995, Gastroenterologist, V3, P220
[2]   GLUTATHIONE AS A PRIMARY OSMOTIC DRIVING FORCE IN HEPATIC BILE FORMATION [J].
BALLATORI, N ;
TRUONG, AT .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (05) :G617-G624
[3]   RELATION BETWEEN BILIARY GLUTATHIONE EXCRETION AND BILE ACID-INDEPENDENT BILE-FLOW [J].
BALLATORI, N ;
TRUONG, AT .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (01) :G22-G30
[4]  
BALLATORI N, 1986, J BIOL CHEM, V261, P7860
[5]   INTRACELLULAR ALKALINIZATION STIMULATES BILE-FLOW AND VESICULAR-MEDIATED EXOCYTOSIS IN IPRL [J].
BRUCK, R ;
BENEDETTI, A ;
STRAZZABOSCO, M ;
BOYER, JL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (02) :G347-G353
[6]   NO MODULATES THE APICOLATERAL CYTOSKELETON OF ISOLATED HEPATOCYTES BY A PKC-DEPENDENT, CGMP-INDEPENDENT MECHANISM [J].
BURGSTAHLER, AD ;
NATHANSON, MH .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 269 (05) :G789-G799
[7]   AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION [J].
CORBETT, JA ;
TILTON, RG ;
CHANG, K ;
HASAN, KS ;
IDO, Y ;
WANG, JL ;
SWEETLAND, MA ;
LANCASTER, JR ;
WILLIAMSON, JR ;
MCDANIEL, ML .
DIABETES, 1992, 41 (04) :552-556
[8]   NITRIC-OXIDE BLOCKS BILE CANALICULAR CONTRACTION BY INHIBITING INOSITOL TRISPHOSPHATE-DEPENDENT CALCIUM MOBILIZATION [J].
DUFOUR, JFJ ;
TURNER, TJ ;
ARIAS, IM .
GASTROENTEROLOGY, 1995, 108 (03) :841-849
[9]  
EBERLE D, 1981, J BIOL CHEM, V256, P2115
[10]   HEPATOBILIARY TRANSPORT OF GLUTATHIONE AND GLUTATHIONE CONJUGATE IN RATS WITH HEREDITARY HYPERBILIRUBINEMIA [J].
ELFERINK, RPJ ;
OTTENHOFF, R ;
LIEFTING, W ;
DEHAAN, J ;
JANSEN, PLM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :476-483